Huntington Bancshares Incorporated (HBAN) Stock Analysis
Is HBAN a good investment?
Huntington Bancshares Incorporated (HBAN) has a Plutrex AI rating of 61.0/100 as of October 02, 2026, indicating a Hold consensus. The stock is not classified as halal-compliant. Key strength: PEG of 0.92 is 18.5% below industry average of 1.12 — HBAN is the cheapest growth-adjusted stock in the regional bank peer group; P/B of 1.03x near tangible book establishes a durable valuation floor and limits catastrophic downside. Main concern: Management confirmed cuts to 2026 NII and 2027 EPS/revenue outlook (headlines: 'Huntington Bancshares Cuts 2027 Outlook as Margin, Loan Growth Pressures Mount'; 'Interest Rate Pressures Reduce Upside') directly undermine the 32.4% next-year EPS growth estimate that is the primary PEG-based undervaluation driver — if this growth fails to materialize, the stock at 11.71x P/E on flat/declining earnings loses its cheapness argument.
Investment Summary
Huntington Bancshares (HBAN) at $15.19 remains a moderately undervalued regional bank recovery play with a difficult near-term news backdrop. The core valuation case is intact: PEG of 0.92 (vs. industry 1.12), P/E of 11.71x (vs. industry 12.47x), and P/B of 1.03x near tangible book all signal undervaluation. The 32.4% next-year EPS growth estimate drives the PEG signal, though management's confirmed cuts to 2026 NII guidance and the 2027 outlook revision (headlines: 'Huntington Bancshares Cuts 2027 Outlook as Margin, Loan Growth Pressures Mount' and 'Interest Rate Pressures Reduce Upside') introduce execution risk that tempers conviction. ROE of 9.0% remains 22.6% below the industry average of 11.57%, the most critical structural weakness. Analyst consensus target of $20.12 implies 32.5% upside. The stock has drifted -0.8% from $15.31 to $15.19 in the past week with the consensus target also trimmed -0.5% from $20.22 to $20.12 — incrementally negative but not alarming. This is a low-conviction Buy thesis contingent on the earnings recovery materializing.
Key Strengths
- PEG of 0.92 is 18.5% below industry average of 1.12 — HBAN is the cheapest growth-adjusted stock in the regional bank peer group; P/B of 1.03x near tangible book establishes a durable valuation floor and limits catastrophic downside
- D/E of 0.57 is 45% below industry average of 1.04, providing superior balance sheet conservatism; FCF of $2.957 billion annually funds the increased 2027 buyback program, delivering tangible capital return even in a trough earnings environment
- Operating margin of 41.93% and net margin of 15.73% both exceed industry averages (40.31% and 13.69% respectively) by meaningful margins — the underlying business model generates above-peer operational efficiency that persists through the earnings trough
Key Concerns
- Management confirmed cuts to 2026 NII and 2027 EPS/revenue outlook (headlines: 'Huntington Bancshares Cuts 2027 Outlook as Margin, Loan Growth Pressures Mount'; 'Interest Rate Pressures Reduce Upside') directly undermine the 32.4% next-year EPS growth estimate that is the primary PEG-based undervaluation driver — if this growth fails to materialize, the stock at 11.71x P/E on flat/declining earnings loses its cheapness argument
- ROE of 9.0% is 22.6% below the industry average of 11.57% and likely near or below HBAN's cost of equity — a bank not earning above its cost of capital cannot justify P/B sustainably above 1.0x, and the combination of negative price trend (-0.8% past week), declining analyst target (-0.5% to $20.12), and management guidance cuts creates a mild but persistent negative drift
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
HBAN's fundamentals present a classic recovery bank profile. Operating margin of 41.93% beats the industry average of 40.31% by 160 bps, and net margin of 15.73% exceeds the industry average of 13.69% by 14.9% — genuine operational efficiency advantages. However, ROE of 9.0% lags the industry average of 11.57% by 226 bps, the defining structural weakness: a bank earning below its cost of equity cannot sustainably trade above 1.0x P/B, yet HBAN is at 1.03x — a thin margin of safety. P/E of 11.71x is cheap in absolute terms and below the industry average of 12.47x. The 32.4% forward EPS growth estimate driving the PEG of 0.92 represents a trough-to-recovery trajectory; trailing EPS growth of -7.2% YoY confirms the trough is real. D/E of 0.57 vs. industry average of 1.04 is exceptional balance sheet conservatism. FCF of $2.957 billion supports the elevated 2027 buyback commitment. Cash of $16.607 billion provides ample liquidity. The 47.6% historical revenue growth is acquisition-driven and non-repeatable. The central question remains: does the 32.4% forward EPS growth materialize against a backdrop of management's own NII and margin guidance cuts?
News Sentiment
Huntington Bancshares is navigating a challenging stretch that's testing investor patience. The Ohio-based regional bank made waves recently by slashing its 2026 net interest income guidance and cutting its 2027 earnings and revenue outlook — a double dose of bad news that signals management is wrestling with stubborn margin pressure and sluggish loan growth in a difficult interest rate environment. The headline 'Interest Rate Pressures Reduce Upside' captures the core problem: as the Federal Reserve's rate path creates uncertainty, Huntington's ability to grow the spread between what it earns on loans and pays on deposits has narrowed, squeezing the profitability engine that regional banks depend on. Not all the news was gloomy, though. In a move that signaled confidence in its capital position, Huntington announced a higher 2027 share buyback commitment — essentially telling shareholders the bank has excess cash and plans to return it. The bank also raised its prime rate to 7.00%, a standard move following Fed policy, and executives presented at Barclays' annual global financial conference, using the platform to communicate strategy directly to institutional investors. The net picture: Huntington is a bank with solid bones — conservative balance sheet, healthy free cash flow, and above-average operating margins — fighting through a temporary headwind in net interest income. Whether the promised earnings recovery arrives on schedule will determine if patient investors get rewarded or stuck holding a value trap.
Risk Assessment
PRIMARY RISK: The 32.4% next-year EPS growth estimate collapses if management's NII/margin headwinds persist beyond current guidance — this would eliminate the PEG-based undervaluation thesis and leave the stock trading at 11.71x trough earnings with no near-term catalyst. SECONDARY RISK: ROE of 9.0% below the industry's 11.57% average means the bank is not earning above its cost of equity; prolonged sub-cost-of-equity returns justify continued P/B compression toward or below 1.0x. MITIGATION: The 1.03x P/B floor is a genuine structural support — at $13.75 stop (approximately 1.0x tangible book), the market would be pricing in balance sheet impairment not supported by D/E of 0.57 or FCF of $2.957B. The increased 2027 buyback signals management confidence in capital adequacy. Math: Entry $15.00 midpoint, analyst target $20.12 = +34.1% upside; stop $13.75 = -8.3% downside; risk/reward = 34.1/8.3 = 4.1:1 (adjusted downward for guidance cut risk to ~3.4:1 on a probability-weighted basis). Position capped at 2.0% given low conviction.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is HBAN a halal stock?
No, Huntington Bancshares Incorporated (HBAN) is currently not classified as halal by AAOIFI criteria.
What is Plutrex's AI rating for HBAN?
Huntington Bancshares Incorporated (HBAN) has a Plutrex AI rating of 61.0/100 with a Hold consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is HBAN a good investment?
According to Plutrex AI, HBAN has a Hold rating (61.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in HBAN?
US stocks like HBAN can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in HBAN?
Plutrex AI identifies the main risks for HBAN by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.